EX-23.1 8 acrs-20181231ex231d15f5f.htm EX-23.1 acrs_Ex23_1

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-212095) and Form S-8 (Nos. 333-223922, 333-220149, 333-216703, 333-210379, and 333-307434) of Aclaris Therapeutics, Inc. of our report dated March 18, 2019 relating to the financial statements, which appears in this Form 10-K. 

 

/s/ PricewaterhouseCoopers LLP

 

Philadelphia, Pennsylvania

March 18, 2019